Effectiveness of an anti‐inflammatory drug, loxoprofen, for patients with nocturia
Authors:
- 1 August 2005
- journal article
- clinical trial
- Published by Wiley in International Journal of Urology
- Vol. 12 (8) , 779-782
Abstract
Aim: There is increasing evidence that non‐steroidal anti‐inflammatory drugs are effective for the treatment of nocturia. In this study, we attempted to investigate the role of loxoprofen sodium (loxoprofen) in the therapeutic management of patients with nocturia. Methods: Fifteen benign protastatic hyperplasia and/or overactive bladder patients (13 males and 2 females, 71.1 ± 1.5 years old) with three or more voids per night were involved. These patients had received standard drug therapy. Although these patients had received standard drug therapy for more than half a year, they had still three or more episodes of nocturia. The patients took a single dose of 60 mg of loxoprofen at night prior to sleep. Before and 1 week after the initiation of this therapy, the effects of this treatment were assessed by frequency volume chart and a questionnaire. Results: In the questionnaire, seven patients answered as excellent, six patients demonstrated improvement of their symptoms, two patients did not show a significant change in their symptoms and no patients demonstrated a deterioration in the symptoms. In frequency volume chart, total void per day, total void per night, total urine volume per day, total night urine volume per day and single voided volume in the night before and after this treatment were 9.97 ± 0.81 and 8.99 ± 0.74 per day, 3.82 ± 0.25 and 1.82 ± 0.27 per night, 1349 ± 81 and 1258 ± 91 mL per day, 567 ± 46 and 325 ± 51 mL per night, and 143 ± 13 and 149 ± 10 mL, respectively. Conclusions: Loxoprofen can be effective and useful for patients with nocturia. Our data suggest that the main mechanism of this effect is to decrease urine production during a night's sleep.Keywords
This publication has 9 references indexed in Scilit:
- Loxoprofen inhibits facilitated micturition reflex induced by acetic acid urinary bladder infusion of the ratsBiomedical Research, 2005
- Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping.2004
- Increased urinary nitrite excretion in primary enuresis: effects of indomethacin treatment on urinary and serum osmolality and electrolytes, urinary volumes and nitrite excretionBJU International, 2002
- The standardisation of terminology in nocturia: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- The value of aspirin in controlling the symptoms of nocturnal polyuriaBJU International, 2001
- Indomethacin and symptomatic relief of benign prostatic hyperplasiaJAMA, 1995
- Prostanoids as local modulators of reflex micturitionPharmacological Research, 1992
- Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-Na, an anti-inflammatory prodrugBiochemical Pharmacology, 1991
- Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl)phenyl] propionate dihydrate (CS-600), a new anti-inflammatory drug, and its active metabolite in vitro and in vivoBiochemical Pharmacology, 1984